Results 231 to 240 of about 11,743,275 (304)

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Reimagining public-private partnerships for primary health care in Africa: a governance and systems analysis of emerging models in Botswana. [PDF]

Front Public Health
Seleke TL.
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Health financing strategies for achieving Universal Health Coverage in low- and middle-income countries: a narrative review. [PDF]

Front Public Health
Bashir SG, Abdi YH, Ibrahim Issack Z, Abdullahi Khalif I, Ahmed Ali S, Mohamed Ali S, Mohamed Abdi B, Abdullahi Hubow Y, Mohamed Abdi A, Sharif Abdi M, Ibrahim Ahmed N, Burhan Abdullahi Y, Hassan GD.   +12 more
europepmc   +1 more source

Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe

British Journal of Clinical Pharmacology, EarlyView.
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis, Christine Leopold, Joyce M. Hoek, Raymond M. Schiffelers, Marie L. De Bruin   +4 more
wiley   +1 more source

Who is really shaping global health reform? [PDF]

PLOS Glob Public Health
Alpeza F, Rahman-Shepherd A.
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Public-private configuration in health systems and inequalities in Latin America: a scoping review. [PDF]

Cad Saude Publica
Anjos EFD, Pereira AMM, Oliveira SC, Flores-Quispe MDP, Pinto Junior EP, Machado CV.   +5 more
europepmc   +1 more source

Public Service Reform

The International Journal of Humanities & Social Studies, 2019
openaire   +2 more sources